INTRODUCTION
Streptococcus pyogenes are pathogenic bacteria in humans responsible for common throat and skin infections. They also cause more rare and severe acute infections, whereas rheumatic heart disease and glomerulonephritis are clinically important sequelae following S. pyogenes infections. S. pyogenes bacteria express surface proteins with high and specific affinity for several human plasma proteins such as fibrinogen, albumin and Igs. The best-characterized of these surface molecules are the M proteins and the M-like proteins binding Ig (for references see Fischetti, 1989; Boyle, 1990; Kehoe, 1994) . M proteins are regarded as major virulence determinants in S. pyogenes by conferring on the bacteria the ability to resist phagocytosis, whereas the role for M-like proteins in virulence and pathogenicity is still unclear.
Plasma kininogens, i.e. high molecular weight (H-)kininogen and low molecular weight (L-)kininogen, are multifunctional proteins of complex structure. The two forms of kininogens are generated by alternative splicing of the primary kininogen gene transcript and share their N-terminal domains D1-D4 whereas they differ in their C-terminal domains, D5H/D6H and D5L, respectively (for references see Muller-Esterl et al., 1988) . Domains D1-D3 are ofcystatin-like structure and inhibit cysteine proteinases such as calpain (D2) and papain (D2, D3). Furthermore, D3 interacts with platelets and endothelial cells and inhibits thrombin-induced platelet activation (Jiang et al., 1992) . Domain D4 holds the kinin sequence. The function of D5L of Lkininogen is still unknown. H-kininogen exposes two unique domains at its C-terminus, i.e. DSH which binds to subendothelial surface, and D6H which forms equimolar complexes with prekallikrein and factor XI, respectively. The latter two domains mediate the role of H-kininogen in contact activation (de la Cadena and Colman, 1991) . from S. pyogenes of three different M protein serotypes (Ml, M6 and M46) bound kininogens. The affinity between kininogens and Ml protein was determined to be 5 x 107 M-1 and £ 106 M-1 for high molecular weight (H-kininogen) and low molecular weight kininogen, respectively. The kininogen binding site was tentatively mapped to the N-terminal portion of M protein, and this site does not overlap the specific and separate binding sites for albumin, IgG and fibrinogen. using monoclonal antibodies to, and synthetic peptides of, the kininogen sequence, the major M protein-binding site(s) was mapped to the C-terminal portion of the H-kininogen light chain. We anticipate that the kininogen-M protein interaction contributes to the host-parasite relationship in S. pyogenes infections.
Several observations support the notion that cysteine proteinase activity is crucial to the biological properties of S. pyogenes (Lo et al., 1984; Bjorck et al., 1989; Kapur et al., 1993) . It therefore appeared of interest to investigate a possible interaction between surface proteins of these bacteria and kininogens, the major cysteine proteinase inhibitors of human plasma.
MATERIALS AND METHODS Bacterial strains and culture conditions
Fifty-five strains of S. pyogenes representing 49 different M serotypes and including six M protein-negative mutant strains were obtained from the Institute of Hygiene and Epidemiology, Prague, Czech Republic. The strains have been described (Bjorck et al., 1984; Akesson et al., 1990) . Strain D471 expressing the M6 protein was from the Rockefeller University (Hollingshead et al., 1986) . Streptococci, grown in Todd-Hewitt broth (Difco) at 37°C for 16 h, were harvested by centrifugation (2000 g, 20 min), washed twice in 0.12 M NaCl/0.067 M phosphate, pH 7.2 (PBS) containing 0.02% (w/v) NaN3 (PBSA), and resuspended in PBSA to 2 x 1010 cells/ml. M proteins and Ml protein fragments MI protein from the culture supernatant of strain AP1 (Schmidt and Wadstrom, 1990) was isolated as described (Akesson et al., 1994) . Pepsin fragments of MI protein were generated and purified according to Beachey et al. (1978) Figure 1 Relative locations of the antibody epitopes and of the synthetic peptides in the H-kininogen sequence
The hypothetical domain structure of human H-kininogen is outlined in the centre of the figure.
Top: enlargement of domains D5H/D6H aligning the target epitopes of various monoclonal antibodies to the H-kininogen light chain (HKL series; Kaufmann et al., 1993) . Bottom: enlargement of domain D5H listing the synthetic peptides (HKHIS series; this work). The relative positions of the segments within the mature H-kininogen molecule are given below the bars (Kellermann et al., 1986 (Moravek et al., 1986; Akesson et al., 1994) . Recombinant Ml protein fragments were prepared as described (Akesson et al., 1994) . M6 and M46 proteins were expressed in Escherichia coli and purified from periplasmic lysates (Berge and Sj6bring, 1993) .
Kininogens and antibodies to kininogens
Kininogens were purified from human plasma as previously detailed (Miiller-Esterl et al., 1988) . Peptides derived from the kininogen sequence were synthesized on a MilliGen 9050 automated continuous flow peptide synthesizer using Pepsyn KA resins (Millipore, Bedford, MA, U.S.A.) and N(9-fluorenyl)-methoxycarbonyl chemistry (Meienhofer et al., 1979) . The amino acid sequences of the peptides and their relative positions within the amino acid sequence of human H-kininogen (Kellermann et al., 1986) are given in Figure 1 . Monoclonal antibodies to human kininogens were raised in mice (Haasemann et al., 1991; Kaufmann et al., 1993 by positive immunoselection on H-kininogen-Sepharose (MullerEsterl et al., 1988; Vogel et al., 1990) .
Other proteins and labelling of proteins
Recombinant protein H was purified as described (Akesson et al., 1990 (Hock et al., 1990 ).
Binding of radiolabelled proteins to bacteria
Bacteria were washed in PBSA containing 0.05 % (w/v) of Tween-20 (PBSAT) and the cell concentration was adjusted to 1% w/v) corresponding to a total of 2 x 109 cells per ml). Bacteria were diluted as indicated and 200 ,ul of cell suspension was incubated with radiolabelled protein in 25 ,ul PBSAT (_ 104 c.p.m.) at room temperature for 30 min. A 2.0 ml volume ofPBSATwas added and the bacteria were centrifuged for 15 min at 1800 g. The radioactivity of the cell pellet was measured in a y-counter and expressed as a percentage of the total amount of 1251-labelled protein added to the cells. Inhibition experiments were performed with excess amounts of unlabelled proteins (Bjorck et al., 1984) . To digest bacterial surface proteins before the addition of radiolabelled protein, bacteria were treated with mutanolysin, papain, pepsin or trypsin as described (Bjorck, 1988) followed by testing for binding activity (see above).
Affinity chromatography CNBr-activated Sepharose 4B, N-hydroxysuccinimide (NHS)-activated Sepharose HP, HiTrap-gels and prepacked 1 ml columns were purchased from Pharmacia (Uppsala, Sweden).
Coupling of proteins to the gels was performed according to the manufacturer's instructions. 1251-labelled H-kininogen was applied to Ml protein-or glycine-HiTrap columns. The columns were extensively washed with PBSAT. Bound material was eluted with 3 M KSCN and the radioactivity of the fractions was measured in a y-counter.
Competitive binding assay and affinity constants Electrophoresis and blotting SDS/PAGE was performed as described by Neville (1971) , using a total concentration of 10 % (w/v) of polyacrylamide and 3.3 % (w/v) ofcross-linker. Samples were boiled for 3 min in the sample buffer containing 2% (w/v) of SDS and 5 % (v/v) of 2-mercaptoethanol. Molecular weight markers were from Sigma. Gels were stained with Coomassie Blue. After electrophoresis the proteins were transferred to poly(vinylidene difluoride) (PVDF) membranes (Immobilon, Millipore) by electroblotting from gels as described by Towbin et al. (1979) , using a Multiphor II semidry blotting apparatus (Pharmacia). Proteins were also directly applied to PVDF membranes using a slot-blot apparatus from Schleicher and Schuell (Dassel, Germany). The membranes were blocked, washed and incubated with 1251-labelled proteins as described (Akesson et al., 1990) . Autoradiography was done at -70°C using Kodak X-Omat S films and Cronex Xtra Plus intensifying screens.
E.I.i.s.a.
The indirect e.l.i.s.a. was performed as detailed earlier ) with minor modifications published elsewhere (Herwald et al., 1993) . Briefly, titre plates (Nunc) were coated with serial dilutions (2n) of the relevant antigen (Ml protein, prekallikrein, a2 HS glycoprotein; 4,g/ml), probed with serial dilutions (2n) of biotinylated H-kininogen (starting concentration 0.5 ,ug/ml; Hock et al., 1990) , and followed by the preformed biotin-avidinperoxidase complex (2 ,ug/ml) and diammonium 2,2-azinobis(3-ethyl-2,3-dihydrobenzothiazoline)-6-sulphonate/H202 For the competitive mode, serial dilutions of the competitor (protein, antibody, peptide; starting concentrations 10 ,ug/ml-25 ,ug/ml) were mixed with an equal volume of biotinylated H-kininogen (0.5 ,ug/ml), and the resultant mixture applied to the precoated titre plate as above.
RESULTS
Binding of radiolabelled kininogens and fibrinogen to S. pyogenes Forty-nine strains of different M serotypes were tested for binding of 1251-labelled H-kininogen, L-kininogen and fibrinogen. Figure 2 shows the results obtained with one H-kininogen preparation and fibrinogen. The majority of the strains (41 out of 49) expressing M protein bound H-kininogen (5 %-59 % of the total activity was taken up by 2 x 109 cells/ml) above the background (defined as < 5 % uptake). (Figure 2 , strains AP72-77) which showed low affinity for both 1251-labelled H-kininogen and fibrinogen. Be- (Figure 4) . However, at higher concentrations pepsin cleaves M proteins in their N-terminal regions (Beachey et al., 1978) and mutanolysin lyses the cells. In summary, the experiments with intact bacteria Figure 8 Mapping of the H-kininogen binding region of Ml protein (a) A schematic representation of Ml protein is shown. Ss is the signal peptide, A the N-terminal domain of the mature protein, Bi and B2 are identical repeats followed by a non-repeated IgGFcbinding domain (S) and three homologous albumin-binding C domains. The D region, finally, includes the putative wall-spanning and membrane-anchoring sequences (Akesson et al., 1994 
Interaction between purified M protein and kininogens
Genes encoding M protein of serotypes 1, 6 and 46 were expressed in E. coli, and the corresponding proteins were purified. M protein of the Ml serotype was also purified from growth medium of S. pyogenes strain API (Akesson et al., 1994) .
Varying amounts (1 ,ug-10,ug) of the M proteins were directly applied to PVDF membranes and incubated with a solution containing '251-labelled H-kininogen ( Figure 5 ). The radiolabelled H-kininogen bound to the various M protein preparations in a concentration-dependent manner. For control we applied protein H, the major IgG-binding surface protein of AP1 which shares structural similarity with M protein in the Cterminal but not in the N-terminal regions (Gomi et al., 1990; Akesson et al., 1994) . Unlike M protein, protein H did not interact with kininogens ( Figure 5 ). Similar results were obtained with 125I-labelled L-kininogen (not shown). To evaluate further the specificity of the kininogen-M protein interaction, we performed Western blot experiments with proteins M 1, M6 M46 (50 kDa-60 kDa) and protein H (42 kDa), respectively (Figure 6a ). Application of 1251-labelled L-kininogen as the probe yielded positive staining for the various M proteins but not for protein H, thus further underlining the specificity of the interaction (Figure 6b) . Similar results were obtained with radiolabelled H-kininogen which gave even stronger signals than Lkininogen (not shown). To further address these differential binding-affinities we immobilized M proteins on Sepharose and applied 1251-labelled H-kininogen (4 x 105 c.p.m./ml). A fraction of 30 %-40 % of the applied H-kininogen was specifically eluted from the MI protein-Sepharose (Figure 7a ), whereas little if any radioactivity was retained by a control matrix, glycineSepharose, under otherwise identical conditions (Figure 7b) Figure 8a ). The Ml fragment lacking domain D (A-C3) still binds kininogen and so does a fragment (PepI) truncated both at the N-and the C-terminus of Ml. By contrast, a fragment (S-C3) covering domains S and C but devoid of domains A, B and D loses its binding activity for kininogen (Figure 8 ). protein complex formation
A competitive e.l.i.s.a. was performed where Ml protein (4 ,ug/ml) was the coating protein, 13 monoclonal antibodies directed against distinct epitopes of the human H-kininogen were the competitors (50 ,ug/ml) and biotinylated H-kininogen (0.5 ,ug/ml) was the probe. Bound Hkininogen was visualized by the biotin-avidin-peroxidase technique. The y-axis gives the relative binding (percent of kininogen binding in the absence of a competitor). The x-axis label groups the antibodies according to their target domains in H-kininogen.
glycoprotein (human fetuin), does not recover the biotinylated H-kininogen from the incubation mixture, thus stressing the specificity of the test system. Using a competitive variant of the same e.l.i.s.a. system we searched for the interference of polyclonal antibodies to the common heavy chain of H-and Lkininogen (1-107) or to the unique light chain H-kininogen (1-108) with the complex-formation between biotinylated Hkininogen and Ml protein. We applied unlabelled H-kininogen and L-kininogen as positive controls and a2-HS glycoprotein as an unspecific competitor. Unlabelled H-kininogen was effective in displacing the biotinylated probe whereas L-kininogen was much less efficient and a2-HS glycoprotein failed to compete at all (Figure 9b ). Antibodies to the unique light-chain portion of H-kininogen were almost as effective as unlabelled H-kininogen while antibodies to the heavy-chain portion shared by the two types of kininogens were poor effectors. These data are consistent with our previous conclusion that H-kininogen binds more avidly to Ml protein than L-kininogen and that the predominant though not exclusive determinants mediating this specific interaction are harboured by the unique light-chain portion of H-kininogen. Kaufmann et al., 1993) were almost equally effective, suggesting that several segments of the H-kininogen light chain contribute to M protein binding.
Because antibody HKL12 directed to D5H was most effective in preventing complex-formation between H-kininogen and M protein, we sought to analyse the effects of peptides derived from D5H on the complex formation. To this end we synthesized five peptides of 18-20 residues in length which almost completely cover domain D5H (cf. Figure 1 ) and applied them in the competitive e.l.i.s.a. (Figure 9c ). Peptide HKHIS-5 corresponding to the extreme C-terminal portion of D5H effectively prevented H-kininogen binding to M protein whereas other peptides were without effect. Together the data from the antibody displacement experiments and from the peptide competition studies indicate that distinct sequence segments dissipated over the light chain domains D5H and D6H (covering positions 441-626 of the Hkininogen sequence, cf. Figure 1 ) contribute directly or indirectly to M protein binding. Our data are compatible with the notion that several possibly discontinuous segments of the H-kininogen light chain form the M protein binding region.
DISCUSSION
M proteins are fibrous, hairlike structures on the surface of S. pyogenes (Swanson et al., 1969) which contribute to the ability of the bacteria to persist in the infected host. Thus, in the absence of type-specific antibodies to the M protein, S. pyogenes resist phagocytosis by polymorphonuclear leucocytes (Lancefield, 1962) . The molecular mechanism(s) behind the antiphagocytic effect of M protein is not fully understood, but it has been suggested that binding to M protein of fibrinogen (Whitnack and Beachey, 1985) and/or factor H of the alternative complement pathway (Horstmann et al., 1988) could play a critical role. Apart from factor H and fibrinogen (Kantor, 1965) , M protein of many serotypes shows affinity for IgG and albumin (Schmidt and Wadstr6m, 1990; Akesson et al., 1994) . The binding sites for albumin, IgG and fibrinogen, respectively, were recently mapped to different regions in Ml protein (Akesson et al., 1994) . Thus, albumin was found to interact with the so-called C repeats in the C-terminal half, IgG with the S domain, and fibrinogen with the A and/or B domains ofMl protein (cf. Figure 8 ). Hence the three most abundant proteins of human plasma have distinct binding regions of Ml protein which do not mutually overlap. This is probably due to the elongated structure of M proteins (Phillips et al., 1981) in which the different binding domains are arranged as pearls on a string. The present work demonstrates that M protein has yet another binding region for the kininogens distinct from that for albumin, IgG or fibrinogen. We have mapped the kininogen-binding region to the N-terminal part of Ml protein. Interestingly, this region shows little sequence similarity among M proteins of different serotypes. Still the vast majority of M serotypes bind kininogens, suggesting that the three-dimensional structure of the binding region is similar in the various M proteins despite their sequence divergence. Our studies indicate that the major binding region for M protein maps to the C-terminal domains of Hkininogen light chain. Finding that L-kininogen also binds to M protein, though with a considerably lower affinity than Hkininogen, points to the possibility that other portions of the kininogens such as the heavy chain could also be involved in M protein binding.
The biological consequences of the various interactions between M protein and extracellular host proteins are still unclear. However, previous work has demonstrated that the binding of physico-chemical surface properties of the microorganisms (Miorner et al., 1980) , which should for instance influence their adherence to epithelial cells. Furthermore, binding of several host plasma proteins to the surface of streptococci might 'camouflage' the invading bacteria thus allowing them to escape from the surveilling host immune system. Kininogens are multifunctional proteins and their presence at the streptococcal surface could affect the host-microbe relationship in more specific ways. S. pyogenes for example produces a cysteine proteinase which is active within the bacterial cell (Lo et al., 1984) , and is also secreted into the culture fluid as a zymogen (Elliott, 1945) which can be activated by reduction and autocatalytic conversion (Liu and Elliott, 1965) . This proteinase, which is identical to streptococcal pyrogenic toxin B (Gerlach et al., 1983) , has been implicated in essential functions such as bacterial growth , activation of interleukin-l,# (Kapur et al., 1993) and mediation of toxic and fatal streptococcal infections in humans (Holm et al., 1992) and in mice . Given the fact that kininogens are potent inhibitors of cell-associated cysteine proteinase such as calpain (Bradford et al., 1993) one might speculate that H-kininogen bound to -the bacterial surface can inhibit the bacterial enzyme via D2/D3 and thereby modulate some of the potential effects of the streptococcal cysteine proteinase.
The accumulation of kininogens at the bacterial surface could also result in the local release of kinins, i.e. proinflammatory agents which increase vascular permeability, contract smooth muscles and induce pain. Such a mechanism could contribute to the rash seen in skin infections and to the redness and edematous membranes of the tonsils and pharynx in cases of pharyngitis caused by S. pyogenes. Finally, kininogens have affinity for several cell types (for references see de la Cadena and Colman, 1991) like platelets, granulocytes and endothelial cells. Therefore kininogens bound to S. pyogenes (primarily via D5H and D6H) could mediate cell-cell interactions between the bacterium and host cells (note that the primary anchor site of kininogens for platelets is located on domain D3).
The host-parasite relationship represents a delicate balance between numerous molecular interactions. The present study further emphasizes the complexity of this relationship and provides a starting point for future work aimed at clarifying some of the mechanisms of importance in microbial virulence and pathogenicity.
